When Boston University professor Ed Damiano set out to raise a new tranche of funding for the startup last year, his hopes were low. Diabetes device makers were struggling to raise money. Here's how he landed $126 million.
In a significant milestone for Alder, the U.S. Food and Drug Administration agreed on April 22 to review the biologics license application for the company’s flagship migraine drug, the company discovered and developed over the last decade. FDA approval could come as early as